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Abstract 1 
Aims Perform wastewater analyses to assess spatial differences and temporal changes of illicit drug 2 
use in a large population. Design Analyses of raw wastewater over a one-week period in 2012 and 3 
2013. Setting, Participants Catchment areas of wastewater treatment plants (WWTPs) across 4 
Europe; 2012: 25 WWTPs in 11 countries (23 cities, total population 11.50 million); 2013: 47 WWTPs 5 
in 21 countries (42 cities, total population 24.74 million). Measurements Excretion products of five 6 
illicit drugs (cocaine, amphetamine, ecstasy, methamphetamine, cannabis) were quantified in 7 
wastewater samples using methods based on liquid chromatography coupled to mass spectrometry. 8 
Findings Spatial differences were assessed and confirmed to vary greatly across European 9 
metropolitan areas. In general, results were in agreement with traditional surveillance data, where 10 
available. While temporal changes were substantial in individual cities and years (P ranging from 11 
insignificant to <10-3), overall means were relatively stable. The overall mean of methamphetamine 12 
was an exception (apparent decline in 2012), as it was influenced mainly by four cities. Conclusions 13 
Wastewater analyses can provide the most up-to-date evidence on illicit drug use in Europe. An 14 
increased number of countries and WWTPs serving rural areas should be considered in the future for 15 
a wider and better representation of the European population to obtain the most detailed 16 
information on illicit drug markets and trends, complementary to existing survey methods. 17 
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1/Introduction 18 
Illicit drug use is a covert and hidden activity that presents methodological challenges for 19 
drug surveillance systems. Questionnaire-based survey methods have traditionally been an 20 
important component of the approaches employed to monitor drug use, but it is recognized that 21 
these methods are not sufficient to adequately and quickly monitor trends in drug use and require 22 
complementary data from other sources [1,2]. The analysis of the excretion products of illicit drugs in 23 
wastewater [wastewater analysis (WWA)] has been explored since 2008 as an additional approach 24 
for estimating illicit drug use within specified regions, i.e. the catchment areas of wastewater 25 
treatment plants (WWTP) [3,4]. While the approach cannot provide information on the behavior of 26 
single users and on their demographics, there are a number of ways in which WWA can complement 27 
other survey methods and provide additional information to better understand the illicit drug 28 
situation. Wastewater data can be obtained within short time-frames, are not prone to response 29 
biases, and can help in identifying the spectrum of illicit drugs being used by a population. This is 30 
potentially important given the emergence of new psychoactive substances [5]. Drug users are often 31 
unaware of the actual substance or mix of substances they are consuming, which makes self-report 32 
data unreliable. Wastewater analysis is therefore a potential approach to detect and estimate use of 33 
new psychoactive substances, however, it has to be noted that more information regarding their 34 
biotransformation pathways is necessary. 35 
Wastewater analysis can provide information on daily, weekly, monthly and annual variations 36 
in illicit drug use. The weekly profile of cocaine and amphetamine-like stimulants use has already 37 
been assessed by collecting consecutive daily wastewater samples, which revealed higher use of 38 
these substances during weekends [6-12]. The monitoring of temporal trends in illicit drug 39 
consumption over a longer period of time (months) by WWA has been evaluated in three studies and 40 
the major conclusions were that there was typically an increase of illicit drug use during holiday 41 
periods [11,13,14]. Wastewater analysis was further applied to detect yearly trends in illicit drug 42 
consumption in Italy and Australia [15,16]. In conclusion, this approach can provide important and 43 
timely information on short- and long-term trends in illicit drug use. 44 
Wastewater studies in different countries have also detected regional variations in illicit drug 45 
use [17-22]. The influence of urbanization on the use of illicit drugs was evaluated in Oregon (USA) 46 
and South Australia and Queensland (Australia), concluding that the use of illicit drugs was higher in 47 
urban regions compared to more rural areas [9,14,23]. Wastewater analysis has also been applied to 48 
detect transnational differences in illicit drug use. The consumption of five substances was evaluated 49 
by analyzing wastewater from 19 European cities for a one-week period in 2011 [24]. Wastewater 50 
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analysis can thus complement survey methods for a better understanding of actual spatial 51 
differences and temporal changes in illicit drug use.  52 
However, until now no international study has been performed covering multiple countries 53 
over multiple years with a common protocol and adequate quality control measures. Therefore, the 54 
aims of this study were to:  55 
1) collect wastewater samples from multiple European locations in 2012 and 2013,  56 
2) calculate population-normalized mass loads of benzoylecgonine [BE; as indicator for cocaine 57 
(COC) use], amphetamine (AMP), methamphetamine (METH), ecstasy [3,4-methylenedioxy-58 
methamphetamine (MDMA)] and 11-nor-9-carboxy-delta9-tetrahydrocannabinol [THC-COOH; as 59 
indicator for tetrahydrocannabinol (THC) use], 60 
3) perform analytical quality control through inter-laboratory tests. 61 
 62 
2/Methods 63 
2.1/Sewer system characterization 64 
Relevant information for each WWTP catchment was systematically gathered by means of a 65 
standardized questionnaire. An extended version of the questionnaire developed for earlier studies 66 
[24,25] was used (Appendix S1). It comprises over 50 questions classified according to importance. 67 
The number of the most important questions per category is indicated in brackets (year 2012/year 68 
2013): General information (1/1), Catchment and population (2/5), Sewer system (2/2), WWTP 69 
influent (1/1), Sampling (5/5), Flow meter (3/3), Sample handling (9/9), Monitoring period (5/5). 70 
2.2/Sampling and analysis 71 
A one-week period was targeted in 2012 (17-23 April) and 2013 (6-12 March). Daily 24-h 72 
composite raw wastewater samples were collected over seven consecutive days. Considering 73 
stability, metabolism and unambiguous indication of drugs actually having been consumed, the most 74 
suitable target residues were targeted: BE, AMP, METH, MDMA and THC-COOH [4]. It has to be noted 75 
that the consumption of COC and THC was monitored through the analysis of their main metabolite 76 
because of higher concentrations and higher stability in wastewater. 77 
Samples were spiked with isotope-labelled internal standards, either filtered and 78 
immediately extracted on solid-phase extraction cartridges or frozen at -20°C until analysis. Each 79 
laboratory used fully validated analytical methods: target compounds present in the liquid phase of 80 
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the wastewater were quantified in final extracts or with direct injection applying liquid 81 
chromatography coupled to tandem mass spectrometry or high-resolution mass spectrometry [25].  82 
For quality assurance, each laboratory participated in yearly inter-laboratory tests [de Voogt 83 
et al., unpublished]. External quality control samples were evaluated (one standard in methanol and 84 
two fortified raw wastewater samples). A reliable estimation of the method limit of quantification 85 
(LOQ) was performed by evaluating the signal-to-noise ratio in these samples. In 2012, one of 14 86 
laboratories did not meet the requirements for any compound in the inter-laboratory test and was 87 
excluded. In 2013, only METH results of one of 15 laboratories had to be excluded.  88 
 89 
2.3/Calculations 90 
Daily mass loads (g/day) of drug residues entering the WWTPs were calculated by multiplying 91 
measured concentrations (ng/L) in daily samples with the corresponding wastewater volumes 92 
(L/day). To compare cities of different sizes, mass loads are normalized by the population size of the 93 
catchment (mg/1000persons/day). The estimated consumption of COC (section 3.1) was back-94 
calculated from the population-normalized mass loads of BE using a correction factor of 3.59 that 95 
takes the urinary excretion rate of COC into account for different dosages and routes of 96 
administration [25].  97 
 98 
2.4/Uncertainty assessment 99 
Mainly four components of uncertainty may affect the estimation of population-normalized 100 
drug loads: sampling (US), chemical analysis (UC), flow rate measurement (UF) and population 101 
estimation (UP). Since the focus of this study is on mass loads in wastewater, uncertainties related to 102 
excretion rates and bio-degradation in sewers are not considered. When estimating the overall 103 
uncertainty UT of a mean value over an n-day monitoring period, uncertainty components that are 104 
random and independent on every day will be reduced by sqrt(n). This applies to US, since each 105 
sample is collected physically independent of the day before. All other components cannot be 106 
reduced by sqrt(n): i) population is only estimated once, ii) chemical analysis is carried out for all 107 
samples in one batch, and iii) if a flow meter measures flows systematically wrong, it will be in the 108 
same direction every day. All components can be considered as independent. As long as US, UC and 109 
UF30% and UP10% (RSD), an estimation of UT is valid with an approximative formula [e.g. 26]. Since 110 
a conservative estimate of UP in our study is 20%, a Monte Carlo simulation was used to avoid 111 
underestimating UT systematically (see Appendix S2). 112 
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3/Results 114 
Table 1 lists participating cities: in 2012, 25 WWTPs in 11 countries were included (23 cities, total 115 
population 11.50 million), in 2013, 47 WWTPs in 21 countries (42 cities, total population 24.74 116 
million). For comparison, also 2011 data [24] was used (21 WWTPs in 11 countries; 19 cities, total 117 
population 14.12 million). Figures 1-5 summarize all results. Countries are ordered based on average 118 
loads over all years. The numbers in brackets indicate cities’ overall ranks. While absolute variability 119 
within one-week periods (grey range) is obviously higher for high loads, relative variability is not 120 
substantially different throughout the entire load range and may vary from year to year even within a 121 
location. The color of lines between the means indicate whether the change from one week in one 122 
year to one week in another year is significant (Wilcox,=0.05). Table 2 summarizes overall means, 123 
separately for cities that participated in all three years (cities in bold in Figures 1-5) and for all cities 124 
per year (excluding cities that exhibited explainable anomalies, i.e. cities in italics in Figures 1-5). 125 
Concentration values that were <LOQ were treated as follows: 1) if all values at a location for a 126 
certain compound were <LOQ, loads were set to zero; 2) if at least one value was >LOQ, values <LOQ 127 
were replaced with 0.5xLOQ. Dashed grey lines indicate a population-weighted overall mean for 128 
2013 (all cities except cities in italics). When weekly patterns were evaluated in 2012, previous 129 
findings were confirmed, i.e. higher loads on weekends for BE, and MDMA and no substantial 130 
variation for AMP, METH and THC-COOH [24] (see Appendix S4).   131 
3. 1/Benzoylecgonine 132 
The highest weekly mean BE loads in the period 2011-2013 were observed in wastewater 133 
from Amsterdam, Antwerp, London and Zurich and were between 400-850 mg/1000persons/day 134 
(Figure 1). Loads were also relatively high (between 200-550 mg/1000persons/day) in Barcelona, 135 
Basel, Geneva, Utrecht and Eindhoven. The lowest values (<100 mg/1000persons/day) were 136 
observed in locations from Northern, Eastern and Southern Europe. These results suggest a clear 137 
geographical difference in cocaine consumption, with higher use in Western Europe. This is further 138 
demonstrated when BE loads in locations from Germany are evaluated. Loads in Dresden (eastern 139 
Germany) are negligible, similar to the amounts seen in the Czech Republic, while loads in Dortmund 140 
(western Germany) are comparable to the loads observed in the Belgian, Dutch and Swiss cities.  141 
The overall population-weighted mean loads of BE for the 16 locations included in all three 142 
years were almost identical (Table 2). This suggests a stable use of COC in the investigated locations 143 
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in the period 2011-2013. Location-specific results from 2011, 2012 and 2013 are generally in 144 
agreement (Figure 1), however, in some cases, variations occurred. An increase in BE loads from 145 
2012 to 2013 was observed in the Belgian and Swiss locations, while a decrease was observed in two 146 
Dutch locations (Utrecht and Amsterdam).   147 
Besides the high variation of mean BE loads observed across Europe, this study also 148 
highlights differences among locations within countries. Results from Belgium, Czech Republic, 149 
Germany, Serbia, Slovakia, Switzerland and Sweden suggest that the consumption of COC is lower in 150 
smaller towns compared to larger cities (Table 1, Figure 1). Qualitatively, this is in agreement with 151 
studies investigating more locations within a country [17-22], although some of these rely on grab 152 
samples or single days only. The difference between Dresden and Dortmund, two cities of similar 153 
size, is attributable to their geographic location within Germany as previously discussed.  154 
The population-weighted mean COC consumption, calculated from BE loads (section 2.3), for 155 
locations included in all study years is similar between years and varies from 887 156 
mg/1000persons/day in 2013 to 912 mg/1000persons/day in 2012. With 366 million people living in 157 
the urbanized regions of the European Union and a mean purity of 39% (SD: 12%) [27, 28], a rough 158 
extrapolation would imply that 832 kg of street purity COC per day is consumed by the urbanized 159 
population in the European Union in 2013. 160 
3.2/Amphetamine and methamphetamine 161 
Because AMP is a urinary metabolite of METH and since AMP in wastewater could 162 
subsequently result from the use of METH, loads of both substances in wastewater have to be 163 
evaluated in parallel. Moreover, the use of certain prescription drugs, such as selegiline, may also 164 
result in traces of AMP and METH in wastewater following its metabolism, however prescription 165 
rates indicate that any contribution would typically be <1% of the total AMP signal [24,29]. The most 166 
frequently amphetamine-like substance detected in the majority of the investigated locations was 167 
AMP. The highest AMP loads were found in Belgium and the Netherlands, followed by locations in 168 
Northern Europe and western Germany. The locations with the highest METH loads were found in 169 
the Czech Republic, Slovakia, eastern Germany and Northern Europe, while the observed METH loads 170 
in the rest of the studied locations was low to even negligible (Figure 2 and 3). The presented results 171 
suggest an apparent geographical difference in the use of the amphetamine-like stimulants. The 172 
consumption of AMP is more widespread in Western Europe, while the use of METH is clearly 173 
focused to Northern Europe, Slovakia and Czech Republic. The German results confirm the 174 
aforementioned trend in the use of amphetamine-like substances. In Dülmen and Dortmund (west), 175 
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relatively high AMP and negligible METH use was observed, while for Dresden (east, proximity to 176 
Czech Republic) the opposite was found.   177 
The weighted mean of METH loads for the cities that were included in all study years 178 
declined by 45% from 2011 to 2013 (Table 2), due to some location-specific changes. For AMP, the 179 
weighted mean of the cities included in the three years is similar (Table 2). In contrast to BE loads, 180 
the difference in AMP and METH loads between smaller towns and bigger cities within a country is 181 
less clear.  182 
 183 
3.3/MDMA 184 
The highest loads of MDMA were found in Western European locations, while locations in 185 
Northern, Eastern and Southern Europe presented substantially lower MDMA loads (Figure 4). This 186 
pattern is comparable to BE and AMP, as demonstrated by the locations within Germany, with low 187 
MDMA loads in Dresden and higher loads in Dortmund. 188 
The weighted mean of MDMA loads for the cities included in all three study years was stable 189 
(Table 2). No significant changes in per capita MDMA loads between years for the individual locations 190 
were observed, with some exceptions (Figure 4). The mass loads of MDMA from Eindhoven in 2012 191 
and 2013 were much higher compared to 2011, and in Utrecht significantly higher loads for MDMA 192 
were observed in 2011 compared to 2012 and 2013. An explanation for these high loads in Utrecht 193 
(2011) and Eindhoven (2012) is most probably a release of unconsumed MDMA into the sewer 194 
system that was confirmed by specific enantiomeric profiling of the wastewater [30]. These outliers 195 
were not taken into account when assessing temporal changes. MDMA loads are generally higher in 196 
larger cities compared to smaller towns, as can be seen in different locations within Belgium, Finland, 197 
Germany, Serbia and Slovakia. A notable exception is St. Gallen in Switzerland that showed MDMA 198 
loads comparable to the larger city of Zurich.  199 
 200 
3.4/THC-COOH 201 
The determination of THC-COOH in wastewater poses some (pre-)analytical challenges, and 202 
as a result not all laboratories could report results for this THC metabolite. Furthermore, results from 203 
the performed inter-laboratory exercises revealed that participating laboratories that reported 204 
results for THC-COOH have satisfactorily comparable good analytical methods (Z-scores within the 205 
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limits), but because of some unknown pre-analytical losses, underestimations of the absolute 206 
amounts are probably made [de Voogt et al., unpublished]. In the present study this is, however, not 207 
a real issue, because the focus lies on the relative comparison of THC-COOH loads.  208 
In contrast to the other investigated substances, no clear geographical pattern could be 209 
observed for THC-COOH loads in the different European locations (Figure 5). The values for 210 
Amsterdam were (expectedly) the highest, since Amsterdam is known for its coffee shops and 211 
because the Netherlands produces large amounts of herbal cannabis with a relatively high content of 212 
THC [31]. Also notable are the high loads observed in the city of Novi Sad, Serbia. 213 
The weighted mean of THC-COOH loads for cities that were included in all three years 214 
showed some subtle variation, pointing out a variable cannabis use (amount or potency) between 215 
2011 and 2013 (Table 2). No clear difference in THC-COOH loads between smaller towns and larger 216 
cities could be observed from the gathered data. 217 
 218 
4/Discussion 219 
4.1/Comparison of wastewater results with surveillance data 220 
Europe has an established multi-indicator system for drug surveillance that is based on 221 
standardized demand and supply information, as well as research and intelligence sources [36]. 222 
Prevalence estimates are derived from a mixture of survey results and indirect statistical methods 223 
that try to estimate the unobserved cases from registers of observed drug users, such as treatment 224 
attendees or arrestees [37]. These methods can provide information on the main classes of users, the 225 
frequency and mode of use of a drug as well as on the purity of the substances available on the 226 
market, while WWA can give objective and timely information on the total amount of a drug used in 227 
a specific area. These methods are highly complementary and, if used together, can substantially 228 
improve the quality of information on drug use patterns. 229 
In terms of prevalence at the population level, the findings from WWA are broadly in 230 
agreement, in respect to relative drug use levels, with existing estimates, although they are not 231 
directly comparable. The wastewater data do however point out the need to consider the 232 
contribution of high and low prevalence areas in the estimates of total drug use within a population. 233 
Due to differences in demographics, the ranking of the city-based estimates reported in this study do 234 
not necessarily have to agree with national survey-based estimates. This points to the need to collect 235 
contextual information for a meaningful interpretation of wastewater data. Future monitoring 236 
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campaigns should therefore i) include more cities with different demographics within a country and 237 
ii) evaluate monitoring design strategies to find an optimum among feasible logistics, sufficient 238 
quality control and representativeness for an entire year [38]. 239 
The spatiotemporal data on drug use data reported are largely, but not totally, in line with 240 
what is observed from surveys and other sources. The stable levels of COC suggested by the 241 
presented wastewater data differs from other demand and supply data, which report a decline in 242 
COC use [39]. With WWA, it is currently not possible to differentiate between smaller number of 243 
people using larger amounts or vice versa or even evaluating differences in consumption due to 244 
changes in purity. The analysis on METH and AMP accords with other data sources. The use of METH 245 
is long established in the Czech Republic, Slovakia and eastern Germany [40] and more recently 246 
supply side data point to an increase use of METH elsewhere; especially in Scandinavian countries 247 
where it has at times displaced AMP. The situation appears quite dynamic and largely supply side 248 
driven- the wastewater data reported here accords with, and complements, the existing analysis of 249 
this situation.   250 
For both MDMA and cannabis use, the picture is less clear. High levels of MDMA and THC use 251 
might be expected in the Dutch cities sampled, but it is surprising that MDMA use stands out so 252 
prominently in respect to some of the other European cities. The most recent supply side data 253 
suggest that there is more MDMA available on the European market and it is interesting to note that 254 
there is no evidence of this from the wastewater data reported here. The findings for THC-COOH in 255 
Amsterdam are not too surprising as it is known for its large non-resident population using cannabis. 256 
 257 
4.2/Uncertainty assessment 258 
Details on estimating US can be found in [32,33]. Applying the same scenario as in [25] – i.e. 259 
1% of users in the population with two relevant, substance-related toilet flushes – results in a 260 
maximum of 20% for a daily value of US. An objective assessment of UC was derived from inter-261 
laboratory tests and does not exceed 30% [de Voogt et al., unpublished]. Operational accuracy of 262 
flow meters (UF) still proves to be a challenge and in this study was assumed conservatively to be 263 
20% [34]. Despite advances in estimating UP [35], it remains difficult to obtain a site-specific estimate 264 
and in our study we assume 20% (RSD) as an average [30, 35]. A conservative estimate of overall 265 
uncertainty for a seven-day average based on WWA is around 46% (RSD) for all substances and 266 
locations (see Appendix S2 for more details). A sensitivity analysis reveals that reducing all four 267 
uncertainty components Ui by about one quarter (US  UF  UP  15%, UC  23%), has the same effect 268 
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as trying to eliminate only one Ui (e.g. UC  0%); in both cases the overall uncertainty would be 269 
around 33%.    270 
In areas with leaky sewers the results from WWA may tend towards an underestimation of 271 
actual illicit drug loads. A certain fraction of the wastewater and illicit drugs discharged from 272 
households may not arrive at the WWTP. Information on the potential amount of exfiltration can be 273 
found in Table 1. Furthermore, in cases where population size is estimate from nutrient loads in the 274 
wastewater stream, the population could be overestimated if industrial contributions are not 275 
properly subtracted. This would lead to an underestimation of population-normalized drug loads. In 276 
contrast, WWA results may tend towards an overestimation of population-normalized drug loads, if 277 
only the residential population was used for normalization but a net increase on workdays is 278 
effective due to commuters. This and additional information is provided in Table 1 and Appendix S3 279 
for further data interpretation. 280 
 281 
 282 
5/Conclusions 283 
Successfully increasing the number of participating cities to 42 in 2013 (2011: 19, 2012: 23) this is 284 
now the biggest application of WWA covering 24.7 million people. The wastewater from 285 
approximately 8 million people was analyzed for BE, AMP, METH and MDMA during a one-week 286 
period over three consecutive years (approximately 4 million for THC-COOH). As such, this study 287 
provides the most actual evidence for the quantification of spatial differences and temporal changes 288 
in the consumption of illicit drugs across European regions. Relatively stable loads for all investigated 289 
substances were observed, except for METH (apparent decline in 2012). In general, spatial 290 
differences were in agreement with surveillance data, where available. Wastewater analysis provides 291 
the possibility to collect, and report, measurements more quickly, cheaply and regularly than is the 292 
current norm for national surveys. Wastewater analysis provides a unique opportunity to obtain 293 
near-real-time data on illicit drug use and for future comparison with other surveillance data or 294 
particularly where such data is missing. Therefore, it should be considered for implementation on an 295 
annual, or even more frequent, basis. Systematically gathering information on catchment 296 
characteristics (sewer system and population) seems as indispensable as inter-laboratory tests for a 297 
meaningful comparison of wastewater data, which requires concerted efforts of numerous partners 298 
and disciplines. 299 
300 
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C
o
u
n
tr
y 
City   WWTP 
Population of the city under 
investigation  
Estimated population in WWTP catchment Targeted 1-week monitoring period  
(n=7days) 
Loss of 
wastewa
ter  
 
Com-
muters 
 
Special 
events 
 2011  
method (year) 2012 
 
method (year) 2013 
 
method (year) 
2011 
 Mar 9-15 
2012 
Apr 17-23 
2013 
Mar 6-12 
BA Sarajevo   Butile C: 291422, M: 515012 (W)     130000 b (2013)      R (2013)
BE 
Antwerp D.   Deurne 498473 (E 2011)   213876 a (2011) 213876 a (2012)       
Antwerp Z.   Zuid 498473 (E 2011) 117200 a (2010) 130218 a (2011) 130218 a (2012)       
Brussels   Noord 1136778 (E 2011) 1027300 b (2011) 953987 b (2012) 953987 b (2013)       
Geraardsbergen   Geraardsbergen  32629 (W)     29047 c  (2011)   Mar 7-13    
Koksijde   Wulpen 31207 (W)     78441 a (2012)   Mar 21-27    
Ninove   Ninove 37295 (W)     36179 c (2013)      
CH 
Basel   ProRheno C: 195743 (L 2013)   260000 c  (2012) 260000 c  (2012)      R (2012) 
Berne   region bern C: 137818 (L 2012)   206655 c (2012) 206700 c  (2012)  Apr 21-27    R (2012) 
Geneva   SIG C: 194458 (L 2013)   410486 c (2012) 410500 c  (2012)  Apr 22-28    R (2012) 
St. Gallen   Au and Hofen (2 WWTPs) C: 74070 (L 2013)   89000 c (2012) 89000 c  (2012)   (n=5)    R (2012) 
Zurich   Werdhölzli C: 394012 (L 2012)   410000 c (2012) 410000 c  (2012)      Y (2012) 
CY 
Nicosia   Pano Deftera 234200 (E 2009)     28000 c (2012)   Mar 21-27   Y (2013) 
Limassol   Amathus 185100 (E2009)     272000 c (2010)   Mar 21-27   Y (2013) 
CZ 
Budweis   COV 93620 (E 2011) 112000 d (2010) 112000 d (2010) 110300 d (2013)      Y (2011) 
Prague   UCOV 1241664 (E 2011)   1300000 c (2011) 1300000 c (2011)       
DE 
Dortmund   Deusen 580956 (E 2012)     371788 c (2010)   Mar 13-19    
Dülmen   Dülmen 46071 (W)     34495 c (2010)      
Dresden   Kaditz 529781 (E 2012)     593050 c (2012)      
DK Copenhagen   Lynetten 501285 (E 2003)     531000 c (2009)   Mar 6-13 (n=7)   
ES 
Barcelona   Baix Llobregat C: 1620943, M: 3202571 (E 2012) 1162000 c (2007) 1162000 c (2010) 1162000 c (2010) Mar 16-22     Y (2012/13) R 
(2013) 
Castellon   Castellon de la Plana C: 180204 (E 2012) 170600 a (2010) 204878 b (2012) 204878 b (2013)   Feb 20-26    
Santiago   Silvouta 95671 (E 2012) 136500 d (2010) 136500 d (2010) 136500 d (2010)  (n=6)      
Valencia   Pinedo I+II° and QB°° (3 WWTPs) C: 797028 (E 2012), M: 1353250 (L 2013) 1839000 a°°/b° (2011)   1357952 e°° (2011) / b° (2013)      R (2011/13)
FI 
Helsinki   Viikinmäki M: 1022139 (E 2009) 780000 a (2009) 780000 a (2009) 780000 a (2009)     -  
Turku   Kakola 178630 (E 2012) *275000 d (2011) 275000 d (2011) 275000 d (2011)  (n=6)    - R (2012) 
FR Paris   Seine Centre+/Grésillon++ C: 2243718 (E 2010), M: 6507783 (E 2006) +774600 b (2011) ++245500 f (2012) +1004000 b (2013)  Apr 21-27    Y (2012) 
GB London   Beckton 8174000 (L 2011) 3400000 a (2010)   3400000 e (2010)  (n=6)   - - 
GR Athens   Psyttalia M: 2989023 (E 2009)     3700000 c (2011)      
HR Zagreb   Central C: 688163, M: 1107623 (W) 650000 c (2001) 650000 c (2001) 650000 c (2011)    -  
IT Milan   Nosedo 1295705 (E 2009) 1250000 c (2010) 1100000 b (2012) 1149477 b (2013)       
NL 
Amsterdam   West 779808 (E 2011) 694800 b (2011) 769000 c (2010) 769000 c (2010)  Apr 17-25 
(n=7) 
   Y (2012) 
Eindhoven   Eindhoven 216036 (E 2011) 448700 b (2011) 450300 c (2005) 450300 c (2005)    -  Y (2011/12) 
Utrecht   Utrecht 311367 (E 2011) 297000 b (2011) 300000 c (2010) 300000 c (2010)  (n=5)    - Y (2011) 
NO Oslo   VEAS 599230 (E 2011) 557000 c (2009) 557000 c (2009) 576000 c (2012)   (n=6)     
PT Lisbon   Alcantara C: 537412, M: 1860256 (E 2012)     426964 c (2011)    (n=6)   
RO Cluj Napoca   Cluj Napoca 304802 (E 2011)     350000 c (2011)    - - 
RS 
Belgrade   Sewer outlet Danube C: 1232731, M: 1659440 (W)     284347 c (2008)   Mar 17-23 (n=6)    
Novi Sad    Sewer outlet Danube M: 341625 (W)     321282 d (2013)   Mar 14-19 (n=6) - - R (2013) 
SE 
Gothenburg   Ryaverket 513751 (E 2010)   664441 c (2011) 664441 c (2011)       
Stockholm   Henriksdals (only 1 of 2 inlets) C: 847073, M: 1550208 (E 2010) 315000 c (2009)        - -  
Umeå   Öns 115473 (E 2010) 115800 c (2010) 115800 c (2010) 115800 c (2010)       
SK 
Bratislava   Central and Petržalka (2 
WWTPs) 
415589 (L 2012)     440000 c (2011)      Y (2013)
Piestany   Piestany 29660 (W)     30000 c (2011)      Y (2013)
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Table 1. Summary of participating cities and wastewater treatment plants (WWTP). More detailed information 
can be found in Supporting information (Appendix S3), which includes raw data and answers from the 
questionnaire. 
 
 Population of entire city/region C: City  M: Metropolitan, greater region (E, W, L): Eurostat, Wikipedia and 
local bureau for population statistics (year)  Method for population estimation in WWTP catchment (year of 
estimate); a, influent nutrient load over corresponding calendar year; b, influent nutrient load over actual 
sampling period; c, census d house connections / drinking water subscribers; e, values adopted from previous 
estimation; f, WWTP different from 2011/13 but wastewater from same catchment (central collection with 
subsequent distribution to different WWTPs). *Population estimate indicated in [24] was erroneous and 
population-normalized consumption estimates are corrected with updated value  Loss of wastewater 
(exfiltration, questionnaire 2013). , no loss expected; , loss indicated (unknown amount or <20%); , loss 
>20% expected; -, information missing  Commuters (work days vs. weekend, questionnaire 2013). , no 
substantial net population in-/decrease due to commuters;  net increase of population on work days; - 
information missing  Special events during/adjacent to monitoring period. Y, please see Supporting 
information Appendix S3 for type of event (year provided in brackets); R, rain before/during monitoring period 
(higher flows but no substantial effect on drug loads expected). 
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Table 2. Population-weighted overall mean loads (units=mg/1000p/d). The loads in cities with all 
concentration values <LOQ were set to 0. Loads between cities range from (close to) 0 up to several 
10-100 mg/1000 person/day implying large SD or 95%-CI for all substances’ overall means. 
Significance of changes is assessed at cities’ individual levels only (see Figures 1-5 and Supporting 
information Appendix S3).     
 
 
BE MDMA AMPH METH THC-COOH 
a b a b a b a b a b 
2011 
{14.12}
 
249 
[8.57] 
311 
[14.12] 
21 
[7.82] 
21 
[13.38] 
29 
[8.12] 
30 
[13.67] 
31 
[7.51] 
22  
[13.07] 
71 
[4.37] 
69  
[7.97] 
2012 
{11.50}
 
254 
[7.94] 
229 
[11.50] 
24 
[7.19] 
20 
[10.75] 
29 
[7.49] 
32  
[11.05] 
23 
[6.89] 
42  
[11.50] 
60 
[3.73 
73  
[9.07] 
2013 
{24.74}
 
247 
[8.77] 
263 
[24.74] 
25 
[8.02] 
18  
[23.99] 
34 
[8.32] 
28 
[24.20] 
17 
[7.71] 
33  
[23.68] 
87 
[4.53] 
80 
[15.55] 
 
a Only cities participating in all 3 years are considered. These cities are labeled in bold in the 
corresponding figures. Cities with “explainable anomalies” for a particular substance are excluded  
from the calculation of overall means and labeled in italic (even if the anomaly occurred only in one 
year).  
b All cities participating in the corresponding year are considered except the ones that were already 
excluded due to “explainable anomalies” in option a. Cities with “explainable anomalies” for a 
particular substance are excluded  from the calculation of overall means and labeled in italic (even if 
the anomaly occurred only in one year).   
{ } Total population in millions monitored (please note: not all substances were measured in all 
cities). 
[ ] Population in millions contributing to the corresponding overall mean. 
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Figure 1. Population-normalized benzoylecgonine (BE) loads of one 1-week period per year. See Table 1 for more information. <LOQ: concentrations in all daily samples were below limit of 
quantification (LOQ). Grey dashed line: 2013 overall mean of all participating cities. Dot color: White: concentrations in all samples were above LOQ; Grey shading: one or more 
concentrations were below LOQ and set to 0.5*LOQ (the darker the grey, the more concentrations were below LOQ). Numbers in brackets: cities’ rank (average over all available years). Font: 
Cities in bold participated in all three years and were used to calculate annual overall means (see Table 2). Cities in italic exhibited abnormal high values in at least one year (see text for more 
details). All p-values can be found in Supporting information Appendix S3. 
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Figure 2. Population-normalized amphetamine (AMP) loads of one 1-week period per year. See Table 1 for more information. <LOQ: concentrations in all daily samples were below limit of 
quantification (LOQ). Grey dashed line: 2013 overall mean of all participating cities (except Eindhoven). Dot color: White: concentrations in all samples were above LOQ; Grey shading: one or 
more concentrations were below LOQ and set to 0.5*LOQ (the darker the grey, the more concentrations were below LOQ). Numbers in brackets: cities’ rank (average over all available years). 
Font: Cities in bold participated in all three years and were used to calculate annual overall means (see Table 2). Cities in italic exhibited abnormal high values in at least one year (see text for 
more details). All p-values can be found in Supporting information Appendix S3. 
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Figure 3. Population-normalized methamphetamine (METH) loads of one 1-week period per year. See Table 1 for more information. <LOQ: concentrations in all daily samples were below limit 
of quantification (LOQ). Grey dashed line: 2013 overall mean of all participating cities. Dot color: White: concentrations in all samples were above LOQ; Grey shading: one or more 
concentrations were below LOQ and set to 0.5*LOQ (the darker the grey, the more concentrations were below LOQ). Numbers in brackets: cities’ rank (average over all available years). Font: 
Cities in bold participated in all three years and were used to calculate annual overall means (see Table 2). Cities in italic exhibited abnormal high values in at least one year (see text for more 
details). All p-values can be found in Supporting information Appendix S3. 
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Figure 4. Population-normalized MDMA loads of one 1-week period per year. See Table 1 for more information. <LOQ: concentrations in all daily samples were below limit of quantification 
(LOQ). Grey dashed line: 2013 overall mean of all participating cities (except Utrecht and Eindhoven). Dot color: White: concentrations in all samples were above LOQ; Grey shading: one or 
more concentrations were below LOQ and set to 0.5*LOQ (the darker the grey, the more concentrations were below LOQ). Numbers in brackets: cities’ rank (average over all available years). 
Font: Cities in bold participated in all three years and were used to calculate annual overall means (see Table 2). Cities in italic exhibited abnormal high values in at least one year (see text for 
more details). All p-values can be found in Supporting information Appendix S. 
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Figure 5. Population-normalized THC-COOH loads of one 1-week period per year. See Table 1 for more information. <LOQ: concentrations in all daily samples were below limit of 
quantification (LOQ). Grey dashed line: 2013 overall mean of all participating cities. Dot color: White: concentrations in all samples were above LOQ; Grey shading: one or more 
concentrations were below LOQ and set to 0.5*LOQ (the darker the grey, the more concentrations were below LOQ). Numbers in brackets: cities’ rank (average over all available years). Font: 
Cities in bold participated in all three years and were used to calculate annual overall means (see Table 2). Cities in italic exhibited abnormal high values in at least one year (see text for more 
details). All p-values can be found in Supporting information Appendix S3. 
